LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.48 | 771.67 | 4815 | 11685 | 0.4121 | 0.5952 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.48 | 771.67 | 6847 | 11685 | 0.5860 | 0.7451 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 80.48 | 771.67 | 4693 | 11685 | 0.4016 | 0.5848 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.69 | 771.67 | 4990 | 11974 | 0.4167 | 0.6030 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.69 | 771.67 | 7085 | 11974 | 0.5917 | 0.7515 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.69 | 771.67 | 4650 | 11974 | 0.3883 | 0.5747 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.92 | 771.67 | 5039 | 12266 | 0.4108 | 0.6003 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.92 | 771.67 | 7302 | 12266 | 0.5953 | 0.7562 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.92 | 771.67 | 4706 | 12266 | 0.3836 | 0.5731 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.14 | 771.67 | 5110 | 12592 | 0.4058 | 0.5988 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.14 | 771.67 | 7427 | 12592 | 0.5898 | 0.7543 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.14 | 771.67 | 4636 | 12592 | 0.3682 | 0.5606 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.49 | 771.67 | 816 | 867 | 0.9404 | 0.3909 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 2.49 | 771.67 | 862 | 867 | 0.9934 | 0.9230 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.71 | 771.67 | 926 | 956 | 0.9682 | 0.8020 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.71 | 771.67 | 1018 | 956 | 1.0644 | 1.4470 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.94 | 771.67 | 1023 | 1045 | 0.9788 | 0.9046 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 6.94 | 771.67 | 1114 | 1045 | 1.0659 | 1.3140 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 9.16 | 771.67 | 1107 | 1138 | 0.9723 | 0.9025 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 9.16 | 771.67 | 1181 | 1138 | 1.0373 | 1.1350 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 11.56 | 771.67 | 1184 | 1280 | 0.9246 | 0.7964 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 11.56 | 771.67 | 1277 | 1280 | 0.9972 | 0.9923 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 13.78 | 771.67 | 1287 | 1459 | 0.8817 | 0.7440 | MN20160304_L01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 13.78 | 771.67 | 1363 | 1459 | 0.9337 | 0.8563 | MN20160304_L01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.00 | 771.67 | 1344 | 1585 | 0.8477 | 0.7059 | MN20160304_L01 | J22 |